UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells. Hua J, Zhang Z, Zhang L, Sun Y, et al. Cancer Chemother Pharmacol 2021 Jun 19. pii: 10.1007/s00280-021-04303.

Read + Share

Amedeo Smart

Independent Medical Education

Hua J, Zhang Z, Zhang L, Sun Y, et al. UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells. Cancer Chemother Pharmacol 2021 Jun 19. pii: 10.1007/s00280-021-04303.
PMID: 34146128